• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用时间偏移分布分析估计 COVID-19 的病死率。

Estimating the case fatality ratio for COVID-19 using a time-shifted distribution analysis.

机构信息

Curtin University, School of Electrical Engineering, Computing and Mathematical Sciences, Perth, Australia.

出版信息

Epidemiol Infect. 2021 Jul 19;149:e197. doi: 10.1017/S0950268821001436.

DOI:10.1017/S0950268821001436
PMID:34278986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8438516/
Abstract

Estimating the case fatality ratio (CFR) for COVID-19 is an important aspect of public health. However, calculating CFR accurately is problematic early in a novel disease outbreak, due to uncertainties regarding the time course of disease and difficulties in diagnosis and reporting of cases. In this work, we present a simple method for calculating the CFR using only public case and death data over time by exploiting the correspondence between the time distributions of cases and deaths. The time-shifted distribution (TSD) analysis generates two parameters of interest: the delay time between reporting of cases and deaths and the CFR. These parameters converge reliably over time once the exponential growth phase has finished. Analysis is performed for early COVID-19 outbreaks in many countries, and we discuss corrections to CFR values using excess-death and seroprevalence data to estimate the infection fatality ratio (IFR). While CFR values range from 0.2% to 20% in different countries, estimates for IFR are mostly around 0.5-0.8% for countries that experienced moderate outbreaks and 1-3% for severe outbreaks. The simplicity and transparency of TSD analysis enhance its usefulness in characterizing a new disease as well as the state of the health and reporting systems.

摘要

估算 COVID-19 的病死率(CFR)是公共卫生的一个重要方面。然而,由于疾病的时间进程不确定以及病例诊断和报告困难,在新疾病爆发的早期,准确计算 CFR 是有问题的。在这项工作中,我们提出了一种使用仅随时间推移的公共病例和死亡数据计算 CFR 的简单方法,利用了病例和死亡时间分布之间的对应关系。时间移位分布(TSD)分析生成两个感兴趣的参数:报告病例和死亡之间的延迟时间和 CFR。一旦指数增长阶段结束,这些参数就会随着时间的推移可靠地收敛。对许多国家的早期 COVID-19 爆发进行了分析,并讨论了使用超额死亡和血清流行率数据对 CFR 值进行校正以估计感染病死率(IFR)的问题。虽然不同国家的 CFR 值范围在 0.2%到 20%之间,但对于经历中度爆发的国家,IFR 的估计值大多在 0.5-0.8%之间,对于严重爆发的国家,IFR 的估计值在 1-3%之间。TSD 分析的简单性和透明度增强了其在描述新疾病以及健康和报告系统状态方面的有用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/9348a041daa0/S0950268821001436_fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/3ca766019e5d/S0950268821001436_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/5218e94a603e/S0950268821001436_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/397e4be48bef/S0950268821001436_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/cd69c2beae4d/S0950268821001436_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/3f4f56411c24/S0950268821001436_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/e682d02d2188/S0950268821001436_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/65abd9f8a0c1/S0950268821001436_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/c1b24caa5b9d/S0950268821001436_fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/9348a041daa0/S0950268821001436_fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/3ca766019e5d/S0950268821001436_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/5218e94a603e/S0950268821001436_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/397e4be48bef/S0950268821001436_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/cd69c2beae4d/S0950268821001436_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/3f4f56411c24/S0950268821001436_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/e682d02d2188/S0950268821001436_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/65abd9f8a0c1/S0950268821001436_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/c1b24caa5b9d/S0950268821001436_fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8db/8438516/9348a041daa0/S0950268821001436_fig9.jpg

相似文献

1
Estimating the case fatality ratio for COVID-19 using a time-shifted distribution analysis.利用时间偏移分布分析估计 COVID-19 的病死率。
Epidemiol Infect. 2021 Jul 19;149:e197. doi: 10.1017/S0950268821001436.
2
Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values.对广泛检测的国家的 COVID-19 病例和死亡时间进程进行分析,可以准确地对特定年龄的有症状病死率进行早期估计。
PLoS One. 2021 Aug 18;16(8):e0253843. doi: 10.1371/journal.pone.0253843. eCollection 2021.
3
Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.估算疫情早期 SARS-CoV-2 的死亡率:在中国湖北和欧洲六个地区的建模研究。
PLoS Med. 2020 Jul 28;17(7):e1003189. doi: 10.1371/journal.pmed.1003189. eCollection 2020 Jul.
4
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.对已发表的关于 COVID-19 感染病死率的研究数据的系统回顾和荟萃分析。
Int J Infect Dis. 2020 Dec;101:138-148. doi: 10.1016/j.ijid.2020.09.1464. Epub 2020 Sep 29.
5
Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.在疫苗接种前时代,按年龄、时间和地理位置划分的 COVID-19 感染病死率变化:系统分析。
Lancet. 2022 Apr 16;399(10334):1469-1488. doi: 10.1016/S0140-6736(21)02867-1. Epub 2022 Feb 24.
6
Why case fatality ratios can be misleading: individual- and population-based mortality estimates and factors influencing them.为什么病死率可能具有误导性:个体和人群死亡率估计值及其影响因素。
Phys Biol. 2020 Sep 23;17(6):065003. doi: 10.1088/1478-3975/ab9e59.
7
Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States.加拿大和美国 COVID-19 疫情的病死率时间估算。
CMAJ. 2020 Jun 22;192(25):E666-E670. doi: 10.1503/cmaj.200711. Epub 2020 May 22.
8
Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany.估算德国 COVID-19 大流行期间的有效感染病死率。
BMC Public Health. 2021 Jun 5;21(1):1073. doi: 10.1186/s12889-021-11127-7.
9
Estimation of global case fatality rate of coronavirus disease 2019 (COVID-19) using meta-analyses: Comparison between calendar date and days since the outbreak of the first confirmed case.使用荟萃分析估计 2019 年冠状病毒病(COVID-19)的全球病死率:按日历日期和首例确诊病例出现以来的天数进行比较。
Int J Infect Dis. 2020 Nov;100:302-308. doi: 10.1016/j.ijid.2020.08.065. Epub 2020 Sep 1.
10
The computation of case fatality rate for novel coronavirus (COVID-19) based on Bayes theorem: An observational study.基于贝叶斯定理的新型冠状病毒(COVID-19)病死率计算:一项观察性研究。
Medicine (Baltimore). 2020 May 22;99(21):e19925. doi: 10.1097/MD.0000000000019925.

引用本文的文献

1
Correction of Italian under-reporting in the first COVID-19 wave via age-specific deconvolution of hospital admissions.通过对住院病例进行年龄特异性反卷积校正意大利在第一波 COVID-19 中的低报情况。
PLoS One. 2023 Dec 7;18(12):e0295079. doi: 10.1371/journal.pone.0295079. eCollection 2023.
2
Value of Verbal Autopsy in a Fragile Setting: Reported versus Estimated Community Deaths Associated with COVID-19, Banadir, Somalia.在脆弱环境下口头尸检的价值:索马里巴纳迪尔地区报告的与估计的与新冠病毒相关的社区死亡情况
Pathogens. 2023 Feb 15;12(2):328. doi: 10.3390/pathogens12020328.
3
Evolution of the lethality due to SARS-CoV-2 in Spain according to age group and sex.

本文引用的文献

1
Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020.2020 年 3 月至 10 月,比利时全国连续前瞻性横断面研究中针对 SARS-CoV-2 的 IgG 抗体血清阳性率-残留样本。
Euro Surveill. 2022 Mar;27(9). doi: 10.2807/1560-7917.ES.2022.27.9.2100419.
2
Simpson's Paradox in COVID-19 Case Fatality Rates: A Mediation Analysis of Age-Related Causal Effects.新冠病毒疾病病死率中的辛普森悖论:年龄相关因果效应的中介分析
IEEE Trans Artif Intell. 2021 Apr 14;2(1):18-27. doi: 10.1109/TAI.2021.3073088. eCollection 2021 Feb.
3
Infection fatality rate of COVID-19 inferred from seroprevalence data.
根据年龄组和性别划分的西班牙因 SARS-CoV-2 导致的病死率演变情况。
Sci Rep. 2022 Dec 21;12(1):22052. doi: 10.1038/s41598-022-25635-y.
4
The Impact and Progression of the COVID-19 Pandemic in Bulgaria in Its First Two Years.新冠疫情头两年在保加利亚的影响与发展
Vaccines (Basel). 2022 Nov 10;10(11):1901. doi: 10.3390/vaccines10111901.
5
Analysis of China's fight against COVID-19 from the perspective of policy tools-policy capacity.从政策工具-政策能力角度分析中国抗击新冠肺炎疫情
Front Public Health. 2022 Sep 20;10:951941. doi: 10.3389/fpubh.2022.951941. eCollection 2022.
6
Synergistic influence of air temperature and vaccination on COVID-19 transmission and mortality in 146 countries or regions.气温和疫苗接种对 146 个国家或地区 COVID-19 传播和死亡率的协同影响。
Environ Res. 2022 Dec;215(Pt 1):114229. doi: 10.1016/j.envres.2022.114229. Epub 2022 Aug 30.
7
COVID-19: The Political Economy of a Global Pandemic.《新冠疫情:一场全球大流行病的政治经济学》
Dev Change. 2022 May 5. doi: 10.1111/dech.12711.
基于血清流行率数据推断的 COVID-19 感染病死率。
Bull World Health Organ. 2021 Jan 1;99(1):19-33F. doi: 10.2471/BLT.20.265892. Epub 2020 Oct 14.
4
A novel comprehensive metric to assess effectiveness of COVID-19 testing: Inter-country comparison and association with geography, government, and policy response.一种评估 COVID-19 检测效果的新综合指标:国家间比较及其与地理位置、政府和政策应对的关联。
PLoS One. 2021 Mar 5;16(3):e0248176. doi: 10.1371/journal.pone.0248176. eCollection 2021.
5
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic.英格兰在大流行首次高峰后 SARS-CoV-2 抗体流行率。
Nat Commun. 2021 Feb 10;12(1):905. doi: 10.1038/s41467-021-21237-w.
6
Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.西班牙社区居住人群中 SARS-CoV-2 的感染病死率:全国血清流行病学研究。
BMJ. 2020 Nov 27;371:m4509. doi: 10.1136/bmj.m4509.
7
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany.德国超级传播事件中 SARS-CoV2 的感染病死率。
Nat Commun. 2020 Nov 17;11(1):5829. doi: 10.1038/s41467-020-19509-y.
8
A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.一种双抗原酶联免疫吸附测定法可用于评估低传播环境中严重急性呼吸综合征冠状病毒 2 抗体的血清流行率。
J Infect Dis. 2021 Jan 4;223(1):10-14. doi: 10.1093/infdis/jiaa623.
9
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.对已发表的关于 COVID-19 感染病死率的研究数据的系统回顾和荟萃分析。
Int J Infect Dis. 2020 Dec;101:138-148. doi: 10.1016/j.ijid.2020.09.1464. Epub 2020 Sep 29.
10
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的血清流行率随年龄显著变化:大规模人群筛查的初步结果。
J Infect. 2020 Dec;81(6):e10-e12. doi: 10.1016/j.jinf.2020.09.021. Epub 2020 Sep 19.